
Zhipu AI’s launch of China’s first answer to Project Glasswing signals a shift in how the country’s top artificial intelligence labs approach global cybersecurity, according to a researcher.
The Beijing-based firm – now known internationally as Z.ai – announced its new GLM-5.3 model on Friday alongside the launch of its “Shield of Open Source” initiative. The programme offers free security audits to help users patch software vulnerabilities, as well as automated code-auditing tools via its ZCode platform.
It also provides free model usage quotas to the open-source community.
The initiative comes amid an escalating global debate over whether open-weight models amplify cyber risks by lowering the technical barrier for attackers. Zhipu pledged stricter oversight while implementing a layered risk-review system for GLM-5.3 that blocks high-risk requests without disrupting routine, low-risk developer tasks.
The model’s most sensitive offensive capabilities would be “reserved exclusively for verified users” under a restricted access plan dubbed “Cybersecurity Trusted Access”, Zhipu said.
“In this spirit, Z.ai appears to be proposing a kind of Project Glasswing with Chinese characteristics that sees openness as an asset rather than a drawback,” said Gabriel Wagner, an international AI governance researcher at Beijing-based Concordia AI.

Don't Miss:
-
FBI Most Wanted “Chapo Isidro,” Leader of BLO/Guasave Cartel Arrested in Sinaloa, “El Musico” Possibly Killed
-
DEA’s #FugitiveFriday asks for tips on “El Tano” García Corrales, found dead in Sinaloa in 2024
-
Mocorito, Sinaloa: “El Pagador” and “El Chendo” of La FEA, arrested again 15 months after walking free
-
Zapopan: Marines arrest “El Topo,” alleged Los Deltas leader linked to journalist’s kidnapping; three gunmen killed
-
Anabel Hernández claims “El Mayito Gordo” is back in Mexico, fighting Los Chapitos from the Durango sierra

Trump Enjoyed His Asian Spectacle. He Came Home Empty-Handed
Medical device makers have gotten worse at disclosing when their products harm people, new study finds. The FDA let them.
Anatomy of a Chinese loanbook